About this trial
Assess the quality of care and the satisfaction of patients and caregivers when the monitoring of people on HIV pre-exposure prophylaxis (PrEP) is provided by nurses instead of physicians
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male sex assigned at birth, aged ≥ 18 years
Individual at risk of HIV infection
Currently receiving PrEP care and willing to continue follow-up in a hospital setting
Receiving care at a hospital setting by a physician and not objecting to follow-up by a nurse
Disqualifiers
Individual with confirmed HIV infection
Currently receiving nurse care in a hospital setting
Having renal impairment (creatinine clearance < 60 mL/min)
Unable to provide informed consent
Trial design
Parallel
Treatments tested in this trial
Monitoring of PrEP by nurses
Other interventionMonitoring of PrEP by nurses
Monitoring of PrEP by physicians
Other interventionMonitoring of PrEP by physicians
Treatment groups
Trial outcomes
Primary outcomes
Compliance to PrEP
Compliance to PrEP is defined by a composite criterion comprising: * Presence at scheduled follow-up visits at 0, 6, and 12 months AND * Undergoing an HIV screening test before each visit to allow for the prescription of PrEP if the result is negative (+/-14 days) AND * Prescription of PrEP at each visit
Secondary outcomes
Occurrence of sexually transmitted infection (STI)
Assessed by PCR testing for Chlamydia and Neisseria gonorrhoeae, and serological testing for syphilis)
Occurrence of sexually transmitted infection (STI)
Assessed by PCR testing for Chlamydia and Neisseria gonorrhoeae, and serological testing for syphilis)
Occurrence of sexually transmitted infection (STI)
Assessed by PCR testing for Chlamydia and Neisseria gonorrhoeae, and serological testing for syphilis)
Tolerability of PrEP
Plasma creatine level
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: